During the past decade, Fifth MHAT - Sofia EAD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fifth MHAT - Sofia EAD" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Verona Pharma plc" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fifth MHAT - Sofia EAD" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Fifth MHAT - Sofia EAD" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Asthma" (1 trials), "Atrial Fibrillation" (1 trials), "COPD" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Fifth MHAT - Sofia EAD" in a lesser frequency.

Most popular intervention types in "Fifth MHAT - Sofia EAD" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "40 mg Laninamivir Octanoate" (1 trials), "80 mg Laninamivir Octanoate" (1 trials), "Edoxaban" (1 trials) and "Ensifentrine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fifth MHAT - Sofia EAD" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Fifth MHAT - Sofia EAD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Fifth MHAT - Sofia EAD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fifth MHAT - Sofia EAD, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".